-
Mashup Score: 3
Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Source: www.mskcc.orgCategories: General Medicine NewsTweet
-
Mashup Score: 5Post Next 50 - 4 month(s) ago
50 people shaping our society in 2025
Source: www.washingtonpost.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/WWFKd2iKod
-
-
Mashup Score: 4Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod - 4 month(s) ago
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025.
Source: www.mskcc.orgCategories: General Medicine News, Hem/OncsTweet-
And thank you @MSKCancerCenter for also highlighting this https://t.co/8v6udjUFtN
-
-
Mashup Score: 261
Nature – IL-33 induces tertiary lymphoid structures.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
1. Tertiary Lymphoid Structures (TLSs) – on demand lymphoid aggregates that assemble in inflamed tissues/cancer to regulate immunity But how? What molecule triggers? What cells induce? TODAY in @Nature https://t.co/vTh33onmjh Long-term #PDAC survivor PART4 – TLSs 🧵1/25
-
-
Mashup Score: 1
Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Source: www.mskcc.orgCategories: General Medicine News, Hem/OncsTweet-
@m_amisaki @A_Zebboudj @WeillCornell @MSKCancerCenter @DamonRunyon @NIH @NCI @psscra @CpcrMsk @parkerici Nice summary from @MSKCancerCenter -> https://t.co/2c9QxxMo0w
-
-
Mashup Score: 239
Nature – IL-33 induces tertiary lymphoid structures.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
1. Tertiary Lymphoid Structures (TLSs) – on demand lymphoid aggregates that assemble in inflamed tissues/cancer to regulate immunity But how? What molecule triggers? What cells induce? TODAY in @Nature https://t.co/vTh33onmjh Long-term #PDAC survivor PART4 – TLSs 🧵1/25
-
-
Mashup Score: 37Scientific Research Lead, Head-RNA Therapeutics Lab in New York, New York | Careers at New York, NY - 5 month(s) ago
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. Please review important announcements about vaccination requirements and our upcoming EHR implementation by clickinghere. Important Note for MSK Employees: Your Career Hub profile is submitted to the hiring team as your internal resume. Please be sure your profile is fully complete with your skills, relevant experience and education (if requ
Source: externaltalent-mskcc.icims.comCategories: General Medicine News, Hem/OncsTweet-
In case you missed it, we’re hiring a lead position for the RNA Therapeutics Lab in the Olayan Center for Cancer Vaccines @MSKCancerCenter. If you're a visionary leader with expertise in RNA-based therapies, please consider applying! https://t.co/yWpGSsrZnx
-
-
Mashup Score: 392024-80006 Scientific Research Lead, Head-RNA Therapeutics Lab | Memorial Sloan Kettering Cancer Center - 8 month(s) ago
Company overview The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent,
Source: careers.mskcc.orgCategories: General Medicine News, Hem/OncsTweet-
Consider joining our team as we work toward breakthrough #cancervaccines – The Olayan Center for Cancer Vaccines at #MSKCancerCenter is currently recruiting a Head for our RNA Therapeutics Lab, and we are always looking for talented postdocs! https://t.co/yKowAjEojP
-
-
Mashup Score: 138New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase After - 10 month(s) ago
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Source: www.mskcc.orgCategories: General Medicine News, Hem/OncsTweet-
Randomized phase 2 trial of #mRNAvaccines for #pancreaticcancer NOW OPEN @MSKCancerCenter! More info on enrollment👇🏽 https://t.co/TXKZZTPD2R What did we find in the phase 1?👇🏽 https://t.co/8ndGZADgDH
-
-
Mashup Score: 102RNA vaccines for cancer: Principles to practice - 1 year(s) ago
Though pathogen vaccines are immensely successful, cancer vaccines are largely clinically ineffective. Guasp et al. outline features of emergent RNA cancer vaccines that have achieved recent immunologic breakthroughs with robust immunity against somatic mutation-derived neoantigens—an “ideal” antigen class—and appear poised to deliver clinical breakthroughs in upcoming years.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet-
Interested to learn about #RNAVaccines for #cancer? Our thoughts now in @Cancer_Cell RNA Vaccines for cancer: Principles to Practice https://t.co/FxMJViXTFK Free pdf is here 👇🏽 https://t.co/5c8EIbphox
-
@m_amisaki @A_Zebboudj @WeillCornell @MSKCancerCenter @DamonRunyon @NIH @NCI @psscra @CpcrMsk @parkerici Nice summary from @MSKCancerCenter -> https://t.co/2c9QxxMo0w